Health Care & Life Sciences » Pharmaceuticals | Pharmally International Holding Co. Ltd.

Pharmally International Holding Co. Ltd. | Ownership

Companies that own Pharmally International Holding Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
1,186,581
1.52%
0
0%
07/31/2018
Dimensional Fund Advisors LP
500,347
0.64%
12,960
0%
04/30/2018
BlackRock Fund Advisors
399,555
0.51%
0
0%
09/05/2018
Norges Bank Investment Management
162,944
0.21%
89,297
0%
12/31/2017
BlackRock Advisors (UK) Ltd.
79,466
0.1%
0
0%
09/05/2018
Taiwan Cooperative Securities Investment Trust Co., Ltd.
38,353
0.05%
38,353
1.46%
03/31/2018
Mega International Investment Trust Co., Ltd.
28,201
0.04%
260
0.1%
03/31/2018
TIAA-CREF Investment Management LLC
18,902
0.02%
0
0%
03/31/2018
Analytic Investors LLC
5,882
0.01%
2,000
0%
07/31/2018
State Street Global Advisors Ltd.
5,000
0.01%
0
0%
09/05/2018

About Pharmally International Holding Co.

View Profile
Address
18th Floor
Taipei TP 11012
Taiwan
Employees -
Website http://www.pharmally.com
Updated 07/08/2019
Pharmally International Holding Co., Ltd. engages in the manufacture and sale of infusion and active pharmaceutical ingredient (API) products. It focuses on basic infusion, infusion therapy, and API. Its products include glucose, sodium chloride, glucose & sodium chloride, compound sodium chloride, lactated ringer's, dextran 40 glucose, dextran 20 glucose, ambroxol hydrochloride & glucose, levofloxacin lactate & sodium chloride injections, nikethamide, dextran powder, and levofloxacin lactate powder.